Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Bleomycin

1 Open Trial

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    COGAHOD1331

    07/15/2015

    A Randomized Phase III Study of Brentuximab Vedotin (SGN-35, IND #117117) for Newly Diagnosed High-Risk Classical Hodgkin Lymphoma (cHL) in Children and Adolescents


    Print this page for your doctor